KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 74 filers reported holding KINNATE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,037,890 | -52.6% | 741,350 | +2.5% | 0.00% | – |
| Q2 2023 | $2,190,696 | -84.6% | 723,002 | -68.2% | 0.00% | – |
| Q1 2023 | $14,231,934 | -0.1% | 2,277,109 | -2.5% | 0.00% | – |
| Q4 2022 | $14,248,489 | -47.6% | 2,335,818 | +2.6% | 0.00% | -100.0% |
| Q3 2022 | $27,209,000 | -6.2% | 2,276,816 | -1.0% | 0.00% | 0.0% |
| Q2 2022 | $28,996,000 | +25.3% | 2,299,544 | +11.9% | 0.00% | 0.0% |
| Q1 2022 | $23,143,000 | -36.2% | 2,055,224 | +0.4% | 0.00% | 0.0% |
| Q4 2021 | $36,273,000 | -15.9% | 2,047,035 | +9.2% | 0.00% | 0.0% |
| Q3 2021 | $43,148,000 | +45.5% | 1,874,361 | +47.2% | 0.00% | 0.0% |
| Q2 2021 | $29,648,000 | -21.4% | 1,273,529 | +5.2% | 0.00% | 0.0% |
| Q1 2021 | $37,710,000 | +206.2% | 1,210,198 | +291.0% | 0.00% | – |
| Q4 2020 | $12,314,000 | – | 309,544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $384,738,000 | 41.79% |
| Foresite Capital Management V, LLC | 875,001 | $34,808,000 | 25.78% |
| Vida Ventures Advisors, LLC | 2,747,074 | $109,279,000 | 22.43% |
| VR Adviser, LLC | 1,473,014 | $58,596,000 | 8.62% |
| RA Capital Management | 3,593,052 | $142,932,000 | 2.00% |
| Logos Global Management LP | 569,602 | $22,659,000 | 1.94% |
| Boxer Capital, LLC | 1,064,665 | $42,352,000 | 1.36% |
| Orbimed Advisors | 3,847,929 | $153,071,000 | 1.34% |
| HARVARD MANAGEMENT CO INC | 498,001 | $19,810,000 | 1.07% |
| DAFNA Capital Management LLC | 68,121 | $2,710,000 | 0.81% |